Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
|Apr 04, 2022||Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors|
|Mar 02, 2022||Apollo Endosurgery to Participate in the Cowen Healthcare Conference|
|Feb 22, 2022||Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021|
|Feb 10, 2022||Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022|
|Jan 18, 2022||Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access|